Takeda Pharmaceutical Company Limited

Factors to consider:

• Company pays dividends (annually): last record date 2025-09-30, amount 0.67$ (Y2.34%)
• Total employees count: 49578 as of 2019
• Price in estimated range
• Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-03-31 to 2027-03-31

• 2025-03-31 to 2026-03-31 estimated range: [19.35$, 31.80$]
• 2026-03-31 to 2027-03-31 estimated range: [18.86$, 31.21$]

Financial Metrics affecting the TKPHF estimates:

• Positive: with PPE of 71.3 at the end of fiscal year the price was neutral
• Positive: Operating cash flow per share per price, % of 14.26 > 13.24
• Positive: -3.60 < Operating profit margin, % of 7.48
• Negative: negative Industry operating cash flow (median)
• Positive: Industry inventory ratio change (median), % of -1.45 <= -0.15
• Positive: -14.38 < Investing cash flow per share per price, % of -4.95
• Positive: Inventory ratio change, % of -1.11 <= -0.75
• Negative: 0.79 < Interest expense per share per price, % of 1.85
• Positive: -2.95 < Return on assets ratio (scaled to [-100,100]) of 0.75